{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,18]],"date-time":"2026-11-18T10:23:02Z","timestamp":1794997382181,"version":"4.9.1"},"reference-count":29,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2020,6,26]],"date-time":"2020-06-26T00:00:00Z","timestamp":1593129600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2020,6,26]],"date-time":"2020-06-26T00:00:00Z","timestamp":1593129600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Nat Commun"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>Cancer cell metabolism leads to a uniquely acidic microenvironment in solid tumors, but exploiting the labile extracellular pH differences between cancer and normal tissues for clinical use has been challenging. Here we describe the clinical translation of ONM-100, a nanoparticle-based fluorescent imaging agent. This is\u00a0comprised of an ultra-pH sensitive amphiphilic polymer, conjugated with indocyanine green, which rapidly and irreversibly dissociates to fluoresce in the acidic extracellular tumor microenvironment due to the mechanism of nanoscale macromolecular cooperativity. Primary outcomes were safety, pharmacokinetics and imaging feasilibity of ONM-100. Secondary outcomes were to determine a range of safe doses of ONM-100 for intra-operative imaging using commonly used fluorescence camera systems. In this study (Netherlands National Trial Register #7085), we report that ONM-100 was well tolerated, and four solid tumor types could be visualized both in- and ex vivo in thirty subjects. ONM-100 enables detection of tumor-positive resection margins in 9\/9 subjects and four additional otherwise missed occult lesions. Consequently, this pH-activatable optical imaging agent may be clinically beneficial in differentiating previously unexploitable narrow physiologic differences.<\/jats:p>","DOI":"10.1038\/s41467-020-16814-4","type":"journal-article","created":{"date-parts":[[2020,6,26]],"date-time":"2020-06-26T06:03:59Z","timestamp":1593151439000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":174,"title":["Exploiting metabolic acidosis in solid cancers using a tumor-agnostic pH-activatable nanoprobe for fluorescence-guided surgery"],"prefix":"10.1038","volume":"11","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-3740-4554","authenticated-orcid":false,"given":"F. J.","family":"Voskuil","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4228-063X","authenticated-orcid":false,"given":"P. J.","family":"Steinkamp","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"T.","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2613-1506","authenticated-orcid":false,"given":"B.","family":"van der Vegt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.","family":"Koller","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J. J.","family":"Doff","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Y.","family":"Jayalakshmi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J. P.","family":"Hartung","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0726-5098","authenticated-orcid":false,"given":"J.","family":"Gao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8371-4388","authenticated-orcid":false,"given":"B. D.","family":"Sumer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M. J. H.","family":"Witjes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7248-8696","authenticated-orcid":false,"given":"G. M.","family":"van Dam","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"name":"the SHINE study group","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Y.","family":"Albaroodi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"L. B.","family":"Been","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"F.","family":"Dijkstra","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"B.","family":"van Etten","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Q.","family":"Feng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"R. J.","family":"van Ginkel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"K.","family":"Hall","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"K.","family":"Havenga","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J. W.","family":"Haveman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"P. H. J.","family":"Hemmer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"L.","family":"Jansen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S. J.","family":"de Jongh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"G.","family":"Kats-Ugurlu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"W.","family":"Kelder","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S.","family":"Kruijff","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"I.","family":"Kruithof","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"E.","family":"van Loo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J. L. N.","family":"Roodenburg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"N.","family":"Shenoy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"K. P.","family":"Schepman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S. A. H. J.","family":"de Visscher","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2020,6,26]]},"reference":[{"key":"16814_CR1","doi-asserted-by":"publisher","first-page":"1315","DOI":"10.1038\/nm.2472","volume":"17","author":"GM van Dam","year":"2011","unstructured":"van Dam, G. M. et al. Intraoperative tumor-specific fluorescence imaging in ovarian cancer by folate receptor-alpha targeting: first in-human results. Nat. Med. 17, 1315\u20131319 (2011).","journal-title":"Nat. Med."},{"key":"16814_CR2","doi-asserted-by":"publisher","first-page":"283","DOI":"10.1016\/S2468-1253(16)30082-6","volume":"1","author":"NJ Harlaar","year":"2016","unstructured":"Harlaar, N. J. et al. Molecular fluorescence-guided surgery of peritoneal carcinomatosis of colorectal origin: a single-centre feasibility study. Lancet Gastroenterol. Hepatol. 1, 283\u2013290 (2016).","journal-title":"Lancet Gastroenterol. Hepatol."},{"key":"16814_CR3","doi-asserted-by":"publisher","first-page":"2730","DOI":"10.1158\/1078-0432.CCR-16-0437","volume":"23","author":"LE Lamberts","year":"2017","unstructured":"Lamberts, L. E. et al. Tumor-specific uptake of fluorescent bevacizumab-IRDye800CW microdosing in patients with primary breast cancer: a phase I feasibility study. Clin. Cancer Res. 23, 2730\u20132741 (2017).","journal-title":"Clin. Cancer Res."},{"key":"16814_CR4","doi-asserted-by":"publisher","first-page":"3658","DOI":"10.1158\/1078-0432.CCR-14-3284","volume":"21","author":"EL Rosenthal","year":"2015","unstructured":"Rosenthal, E. L. et al. Safety and tumor specificity of cetuximab-IRDye800 for surgical navigation in head and neck cancer. Clin. Cancer Res. 21, 3658\u20133666 (2015).","journal-title":"Clin. Cancer Res."},{"key":"16814_CR5","doi-asserted-by":"publisher","first-page":"5144","DOI":"10.1158\/0008-5472.CAN-18-0878","volume":"78","author":"RW Gao","year":"2018","unstructured":"Gao, R. W. et al. Determination of tumor margins with surgical specimen mapping using near-infrared fluorescence. Cancer Res. 78, 5144\u20135154 (2018).","journal-title":"Cancer Res."},{"key":"16814_CR6","doi-asserted-by":"publisher","first-page":"3350","DOI":"10.1245\/s10434-018-6655-7","volume":"25","author":"CES Hoogstins","year":"2018","unstructured":"Hoogstins, C. E. S. et al. Image-guided surgery in patients with pancreatic cancer: first results of a clinical trial using SGM-101, a novel carcinoembryonic antigen-targeting, near-infrared fluorescent agent. Ann. Surg. Oncol. 25, 3350\u20133357 (2018).","journal-title":"Ann. Surg. Oncol."},{"key":"16814_CR7","doi-asserted-by":"publisher","first-page":"320ra4","DOI":"10.1126\/scitranslmed.aad0293","volume":"8","author":"MJ Whitley","year":"2016","unstructured":"Whitley, M. J. et al. A mouse-human phase 1 co-clinical trial of a protease-activated fluorescent probe for imaging cancer. Sci. Transl. Med. 8, 320ra4 (2016).","journal-title":"Sci. Transl. Med."},{"key":"16814_CR8","doi-asserted-by":"publisher","first-page":"2929","DOI":"10.1158\/1078-0432.CCR-15-2640","volume":"22","author":"CES Hoogstins","year":"2016","unstructured":"Hoogstins, C. E. S. et al. A novel tumor-specific agent for intraoperative near-infrared fluorescence imaging: a translational study in healthy volunteers and patients with ovarian cancer. Clin. Cancer Res. 22, 2929\u20132938 (2016).","journal-title":"Clin. Cancer Res."},{"key":"16814_CR9","doi-asserted-by":"publisher","first-page":"3994","DOI":"10.7150\/thno.43227","volume":"10","author":"FJ Voskuil","year":"2020","unstructured":"Voskuil, F. J. et al. Fluorescence-guided imaging for resection margin evaluation in head and neck cancer patients using cetuximab-800CW: a quantitative dose-escalation study. Theranostics 10, 3994\u20134005 (2020).","journal-title":"Theranostics"},{"key":"16814_CR10","doi-asserted-by":"publisher","first-page":"1546","DOI":"10.1126\/science.1235122","volume":"339","author":"B Vogelstein","year":"2013","unstructured":"Vogelstein, B. et al. Cancer genome landscapes. Science 339, 1546\u20131558 (2013).","journal-title":"Science"},{"key":"16814_CR11","doi-asserted-by":"publisher","first-page":"646","DOI":"10.1016\/j.cell.2011.02.013","volume":"144","author":"D Hanahan","year":"2011","unstructured":"Hanahan, D. & Weinberg, R. A. Hallmarks of cancer: the next generation. Cell 144, 646\u2013674 (2011).","journal-title":"Cell"},{"key":"16814_CR12","doi-asserted-by":"publisher","first-page":"891","DOI":"10.1038\/nrc1478","volume":"4","author":"RA Gatenby","year":"2004","unstructured":"Gatenby, R. A. & Gillies, R. J. Why do cancers have high aerobic glycolysis? Nat. Rev. Cancer 4, 891\u2013899 (2004).","journal-title":"Nat. Rev. Cancer"},{"key":"16814_CR13","doi-asserted-by":"publisher","first-page":"671","DOI":"10.1038\/nrc3110","volume":"11","author":"BA Webb","year":"2011","unstructured":"Webb, B. A., Chimenti, M., Jacobson, M. P. & Barber, D. L. Dysregulated pH: a perfect storm for cancer progression. Nat. Rev. Cancer 11, 671\u2013677 (2011).","journal-title":"Nat. Rev. Cancer"},{"key":"16814_CR14","doi-asserted-by":"publisher","first-page":"326","DOI":"10.1002\/mrm.24664","volume":"71","author":"D Delli Castelli","year":"2014","unstructured":"Delli Castelli, D., Ferrauto, G., Cutrin, J. C., Terreno, E. & Aime, S. In vivo maps of extracellular pH in murine melanoma by CEST-MRI. Magn. Reson Med. 71, 326\u2013332 (2014).","journal-title":"Magn. Reson Med."},{"key":"16814_CR15","doi-asserted-by":"publisher","first-page":"343","DOI":"10.1016\/S0167-8140(84)80077-8","volume":"2","author":"JL Wike-Hooley","year":"1984","unstructured":"Wike-Hooley, J. L., Haveman, J. & Reinhold, H. S. The relevance of tumour pH to the treatment of malignant disease. Radiother. Oncol. 2, 343\u2013366 (1984).","journal-title":"Radiother. Oncol."},{"key":"16814_CR16","doi-asserted-by":"publisher","first-page":"11085","DOI":"10.1021\/ja5053158","volume":"136","author":"X Ma","year":"2014","unstructured":"Ma, X. et al. Ultra-pH-sensitive nanoprobe library with broad pH tunability and fluorescence emissions. J. Am. Chem. Soc. 136, 11085\u201311092 (2014).","journal-title":"J. Am. Chem. Soc."},{"key":"16814_CR17","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/s41551-016-0006","volume":"1","author":"T Zhao","year":"2016","unstructured":"Zhao, T. et al. A transistor-like pH nanoprobe for tumour detection and image-guided surgery. Nat. Biomed. Eng. 1, 1\u20138 (2016).","journal-title":"Nat. Biomed. Eng."},{"key":"16814_CR18","doi-asserted-by":"publisher","DOI":"10.1038\/ncomms13214","volume":"7","author":"Y Li","year":"2016","unstructured":"Li, Y. et al. Molecular basis of cooperativity in pH-triggered supramolecular self-assembly. Nat. Commun. 7, 13214 (2016).","journal-title":"Nat. Commun."},{"key":"16814_CR19","doi-asserted-by":"publisher","first-page":"314","DOI":"10.1038\/s41551-019-0416-1","volume":"4","author":"G Huang","year":"2020","unstructured":"Huang, G. et al. PET imaging of occult tumours by temporal integration of tumour-acidosis signals from pH-sensitive (64)Cu-labelled polymers. Nat. Biomed. Eng. 4, 314\u2013324 (2020).","journal-title":"Nat. Biomed. Eng."},{"key":"16814_CR20","doi-asserted-by":"publisher","first-page":"681","DOI":"10.1016\/j.cell.2015.12.034","volume":"164","author":"CT Hensley","year":"2016","unstructured":"Hensley, C. T. et al. Metabolic heterogeneity in human lung tumors. Cell 164, 681\u2013694 (2016).","journal-title":"Cell"},{"key":"16814_CR21","doi-asserted-by":"publisher","first-page":"37","DOI":"10.2307\/j.ctv39x8m4.7","volume":"9","author":"M Koller","year":"2018","unstructured":"Koller, M. et al. Implementation and benchmarking of a novel analytical framework to clinically evaluate tumor-specific fluorescent tracers. Nat. Commun. 9, 37\u201339 (2018).","journal-title":"Nat. Commun."},{"key":"16814_CR22","doi-asserted-by":"crossref","unstructured":"Warburg, O., Wind, F. & Negelein, E. The metabolism of tumors in the body. J Gen Physiol. 8, 519\u2013530 (1927).","DOI":"10.1085\/jgp.8.6.519"},{"key":"16814_CR23","doi-asserted-by":"publisher","first-page":"5359","DOI":"10.1021\/acs.chemrev.8b00195","volume":"118","author":"Y Li","year":"2018","unstructured":"Li, Y., Wang, Y., Huang, G. & Gao, J. Cooperativity principles in self-assembled nanomedicine. Chem. Rev. 118, 5359\u20135391 (2018).","journal-title":"Chem. Rev."},{"key":"16814_CR24","doi-asserted-by":"publisher","first-page":"13410","DOI":"10.1074\/jbc.M112.426254","volume":"288","author":"K Rajamaki","year":"2013","unstructured":"Rajamaki, K. et al. Extracellular acidosis is a novel danger signal alerting innate immunity via the NLRP3 inflammasome. J. Biol. Chem. 288, 13410\u201313419 (2013).","journal-title":"J. Biol. Chem."},{"key":"16814_CR25","doi-asserted-by":"publisher","first-page":"5601","DOI":"10.1158\/0008-5472.CAN-11-1316","volume":"71","author":"WH Fridman","year":"2011","unstructured":"Fridman, W. H. et al. Prognostic and predictive impact of intra- and peritumoral immune infiltrates. Cancer Res. 71, 5601\u20135605 (2011).","journal-title":"Cancer Res."},{"key":"16814_CR26","doi-asserted-by":"publisher","first-page":"311","DOI":"10.1007\/s10555-007-9065-z","volume":"26","author":"RJ Gillies","year":"2007","unstructured":"Gillies, R. J. & Gatenby, R. A. Hypoxia and adaptive landscapes in the evolution of carcinogenesis. Cancer Metastasis Rev. 26, 311\u2013317 (2007).","journal-title":"Cancer Metastasis Rev."},{"key":"16814_CR27","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1007\/s10555-019-09799-0","volume":"38","author":"S Pastorekova","year":"2019","unstructured":"Pastorekova, S. & Gillies, R. J. The role of carbonic anhydrase IX in cancer development: links to hypoxia, acidosis, and beyond. Cancer Metastasis Rev. 38, 65\u201377 (2019).","journal-title":"Cancer Metastasis Rev."},{"key":"16814_CR28","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1002\/jmri.25838","volume":"47","author":"KM Jones","year":"2018","unstructured":"Jones, K. M., Pollard, A. C. & Pagel, M. D. Clinical applications of chemical exchange saturation transfer (CEST) MRI. J. Magn. Reson Imaging 47, 11\u201327 (2018).","journal-title":"J. Magn. Reson Imaging"},{"key":"16814_CR29","doi-asserted-by":"publisher","first-page":"109","DOI":"10.1053\/j.seminoncol.2010.11.008","volume":"38","author":"CG Hadjipanayis","year":"2011","unstructured":"Hadjipanayis, C. G., Jiang, H., Roberts, D. W. & Yang, L. Current and future clinical applications for optical imaging of cancer: from intraoperative surgical guidance to cancer screening. Semin Oncol. 38, 109\u2013118 (2011).","journal-title":"Semin Oncol."}],"container-title":["Nature Communications"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41467-020-16814-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41467-020-16814-4","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41467-020-16814-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,10,2]],"date-time":"2023-10-02T19:47:54Z","timestamp":1696276074000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41467-020-16814-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,6,26]]},"references-count":29,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2020,12]]}},"alternative-id":["16814"],"URL":"https:\/\/doi.org\/10.1038\/s41467-020-16814-4","relation":{},"ISSN":["2041-1723"],"issn-type":[{"value":"2041-1723","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,6,26]]},"assertion":[{"value":"4 February 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 May 2020","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 June 2020","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"B.D.S. and J.G. are advisors, Y.J., T.Z., and Y.A. are employees and N.S. is a consultant at OncoNano Medicine Inc. B.D.S., J.G., Y.J., T.Z., Y.A., and N.S. are shareholders of OncoNano Medicine Inc. J.P.H. is an owner of JPH Clinical Development Inc and is a consultant at OncoNano Medicine Inc. The research was funded by OncoNano Medicine Inc. G.M.v.D. is a member of the Scientific Advisory Board of SurgVision BV as well as the CEO, founder, and shareholder of AxelaRx\/TRACER BV. The sponsor (OncoNano Medicine Inc.) participated in the study design, the data were analyzed independently of the sponsor. The sponsor delivered technical advice for writing the paper (B.D.S. and J.G.). All other authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"3257"}}